BofA Securities on Hims and Hers (HIMS): 'Dr. Makary’s op-ed in the New York Times is a negative for HIMS'
Tweet Send to a Friend
BofA Securities analyst Allen Lutz reiterated an Underperform rating and $28.00 price target on Hims and Hers (NYSE: HIMS).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
